Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials
2022 · Molecular Therapy — Oncolytics · 52 citations
https://doi.org/10.1016/j.omto.2022.02.019
H
Huiyao Huang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
124
Papers
2.0K
Citations
25
h-index
45
i10-index
Huiyao Huang is an academic researcher from Guangxi Medical University. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Economic and Financial Impacts of Cancer & Global Cancer Incidence and Screening. The author has an h-index of 25, co-authored 106 publications.
ORCID: 0000-0001-6122-7995Papers by this author
worksMedical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002–2011)
2017 · Chinese Journal of Cancer · 48 citations
https://doi.org/10.1186/s40880-017-0242-3
Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial
2023 · BMC Medicine · 40 citations
https://doi.org/10.1186/s12916-023-02804-y
The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials
2022 · Journal of Hematology & Oncology · 23 citations
https://doi.org/10.1186/s13045-022-01227-1
Advances on anticancer new drugs in China and the USA in 2020: from ongoing trial to drug approval
2021 · Journal of the National Cancer Center · 13 citations
https://doi.org/10.1016/j.jncc.2021.08.002
Whole-exome sequencing reveals genetic underpinnings of salivary adenoid cystic carcinoma in the Chinese population
2020 · Journal of genetics and genomics/Journal of Genetics and Genomics · 11 citations
https://doi.org/10.1016/j.jgg.2020.07.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat